When you eat, the food stimulates your gut to release the GLP-1 hormone
As the curtains closed on Ozempic's unexpected weight loss plot twist, the stage was set for a new star to rise: Wegovy (also semaglutide)
During 72 weeks of treatment, people taking tirzepatide at doses of 5, 10, or 15 mg lost an average of 15.0%, 19.5%, and 20.9%, respectively, compared with just 3.1% in people taking a placebo
Likewise, energy metabolism and appetite regulation could be altered in a therapeutic direction (3941)
Your provider mentions retatrutide as the next-generation GLP-1 drug, and you want to know how it stacks up against the tirzepatide prescription already in your fridge
Retatrutide's profile will sharpen as the remaining seven TRIUMPH trials report over 2026